JSBM Pharma Private Limited
About JSBM Pharma Private Limited
Data last updated:
JSBM Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2021PTC058206. Its GSTIN is 23AAFCJ3892D1ZO (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ankit Agrawal and Sumit Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹80.69 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹46,872 (net margin 0.6%) and EBITDA of ₹1.23 Lakh (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 70% over three years.
As per MCA filings, the company has open charges of ₹9.8 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
Company details
Contact details
JSBM Pharma Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address28/10/2 Talawali Chanda, Dewas Naka A.B Road, Indore, Madhya Pradesh, India – 452010
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of JSBM Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of JSBM Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of JSBM Pharma Private Limited, buy the company report.
Financials of JSBM Pharma Private Limited
FY 2025 filings availableJSBM Pharma Private Limited reported revenue of ₹80.69 Lakh (up 182% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 70% over three years, including 182% growth in the latest year. EBITDA rose 106% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.23 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹46,872 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.5% | |||
| Net Profit Margin | 0.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of JSBM Pharma Private Limited, buy the company report.
Board of directors of JSBM Pharma Private Limited
JSBM Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankit Agrawal Also directs: Fair Deal Remedies Private Limited | Director | 29 Oct 2021 | 5 Years 0 Months | Current |
| Sumit Agrawal Also directs: Fair Deal Remedies Private Limited | Director | 29 Oct 2021 | 5 Years 0 Months | Current |
| Barkha Agarwal | Director | 29 Oct 2021 | 5 Years 0 Months | Current |
| Rani Agrawal | Director | 29 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
JSBM Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pee Dee Pharma Pvt Ltd | ₹80.92 Lakh (FY 2025) | -26.0% | Kolkata, West Bengal, India | |||
| Ariaus Biosciences Private Limited | ₹80.87 Lakh (FY 2022) | 192.0% | Kanpur, Uttar Pradesh, India | |||
| Soyuz Healthcare Private Limited | ₹80.75 Lakh (FY 2018) | 482.0% | Delhi, India | |||
| JSBM Pharma Private Limitedthis company | ₹80.69 Lakh (FY 2025) | ₹46,872 | 0.6% | 182.0% | Indore, Madhya Pradesh, India | |
| Cypress Pharmaceuticals Private Limited | ₹80.44 Lakh (FY 2020) | -84.0% | Mumbai, Maharashtra, India | |||
| Usbi Ventures Private Limited | ₹80.37 Lakh (FY 2025) | 194.0% | Ernakulam, Kerala, India |
To see the full peer comparison of JSBM Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Mar 2023 | 100688543 | Idbi Bank Limited | ₹9.8 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
JSBM Pharma Private Limited has 1 court case on record: 1 filed by JSBM Pharma. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gwalior, Madhya Pradesh | Court case (SC NIA) | Filed by the company against an individual | Disposed |
To see the full case history of JSBM Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for JSBM Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
JSBM Pharma Private Limited has 1 active EPFO establishment as of Apr 01, 2024.
GST
JSBM Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAFCJ3892D1ZO | Madhya Pradesh | Active | 04 Nov 2021 |
To see the full GST registrations and return filing status of JSBM Pharma Private Limited, buy the company report.
Recent activity
JSBM Pharma Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Ankit Agrawal was appointed as Director on 29 Oct 2021.
Frequently asked questions
JSBM Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 October 2021 (5+ years old) and is registered under CIN U24230MP2021PTC058206.
JSBM Pharma has 4 current directors:
- Ankit Agrawal - Director
- Sumit Agrawal - Director
- Barkha Agarwal - Director
- Rani Agrawal - Director
The latest financial statements of JSBM Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of JSBM Pharma is 23AAFCJ3892D1ZO, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of JSBM Pharma is U24230MP2021PTC058206. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
JSBM Pharma has 1 court case on record: 1 filed by the company.
JSBM Pharma was incorporated on 29 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of JSBM Pharma by revenue are Pee Dee Pharma Pvt Ltd, Ariaus Biosciences Private Limited, Soyuz Healthcare Private Limited, Cypress Pharmaceuticals Private Limited, Usbi Ventures Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ankit Agrawal was appointed as Director on 29 Oct 2021. Barkha Agarwal was appointed as Director on 29 Oct 2021. Rani Agrawal was appointed as Director on 29 Oct 2021. JSBM Pharma has 4 board changes on record in total.
The registered office of JSBM Pharma is at 28102 Talawali Chanda, Dewas Naka A.B Road, Indore, Madhya Pradesh, India – 452010.
JSBM Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
